4.7 Article

The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture

Journal

NATURE IMMUNOLOGY
Volume 16, Issue 1, Pages 75-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3035

Keywords

-

Categories

Funding

  1. US National Institutes of Health [R0I DK074500, P01 AI045757, R21 CA182598, 5R01 AI039246, P01 HL085607, GM103441]
  2. American Cancer Society
  3. Claudia Adams Barr Program in Innovative Cancer Research
  4. Cancer Research Institute
  5. American Heart Association [SDG7410022]
  6. National Science Foundation

Ask authors/readers for more resources

In lymph nodes, fibroblastic reticular cells (FRCs) form a collagen-based reticular network that supports migratory dendritic cells (DCs) and T cells and transports lymph. A hallmark of FRCs is their propensity to contract collagen, yet this function is poorly understood. Here we demonstrate that podoplanin (PDPN) regulates actomyosin contractility in FRCs. Under resting conditions, when FRCs are unlikely to encounter mature DCs expressing the PDPN receptor CLEC-2, PDPN endowed FRCs with contractile function and exerted tension within the reticulum. Upon inflammation, CLEC-2 on mature DCs potently attenuated PDPN-mediated contractility, which resulted in FRC relaxation and reduced tissue stiffness. Disrupting PDPN function altered the homeostasis and spacing of FRCs and T cells, which resulted in an expanded reticular network and enhanced immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available